Literature DB >> 10564366

Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions.

G E Meredith1, T Farrell, P Kellaghan, Y Tan, D S Zahm, S Totterdell.   

Abstract

It is possible either permanently or transiently to deplete the rat striatum of dopamine. Following such depletions, striatal neurons immunoreactive for tyrosine hydroxylase (TH), aromatic L-amino acid decarboxylase (AADC) or dopamine appear. The presence of dopamine-producing neurons in the striatum has relevance for the treatment of Parkinson's disease, but whether these catecholaminergic phenotypes all produce dopamine is unclear. In the present study we establish that after unilateral 6-hydroxydopamine lesions or methamphetamine administration, striatal TH-immunoreactive neurons differ in size, morphology and location from those that are immunopositive for AADC or dopamine. The TH-positive cells which were localized either to ventral parts of the striatum or to the central and dorsal areas of the caudate-putamen generally have the morphological features of projection neurons, whereas those containing AADC or dopamine were confined to subcallosal positions in the dorsal medial quadrant of the caudate-putamen and resemble small, local-circuit neurons. The fact that AADC-immunoreactive neurons overlap in size, morphology and location with the cells that produce dopamine suggests strongly that this population is dopaminergic. However, the simultaneous appearance of neurons that contain the TH enzyme but clearly do not make dopamine raises questions about the functional role of these cells and the cellular mechanisms responsible for their induction following striatal dopamine loss.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564366     DOI: 10.1046/j.1460-9568.1999.00774.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  23 in total

Review 1.  The interhemispheric connections of the striatum: Implications for Parkinson's disease and drug-induced dyskinesias.

Authors:  Christopher A Lieu; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2011-09-24       Impact factor: 4.077

2.  Anatomical and electrophysiological changes in striatal TH interneurons after loss of the nigrostriatal dopaminergic pathway.

Authors:  Bengi Ünal; Fulva Shah; Janish Kothari; James M Tepper
Journal:  Brain Struct Funct       Date:  2013-10-31       Impact factor: 3.270

3.  Are striatal tyrosine hydroxylase interneurons dopaminergic?

Authors:  Harry S Xenias; Osvaldo Ibáñez-Sandoval; Tibor Koós; James M Tepper
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

4.  Cooperative synthesis of dopamine in the striatum of normal and parkinsonial mice.

Authors:  A R Kim; M V Ugriumov
Journal:  Dokl Biochem Biophys       Date:  2015-03-13       Impact factor: 0.788

5.  Synthesis of dopamine in non-dopaminergic neurons of the mediobasal hypothalamus of adult rats.

Authors:  V I Melnikova; Yu V Lyupina; A V Lavrentieva; A Ya Sapronova; M V Ugrumov
Journal:  Dokl Biol Sci       Date:  2012-11-06

6.  Ultrastructural analysis of sex differences in nucleus accumbens synaptic connectivity.

Authors:  Anne Marie Wissman; Renee M May; Catherine S Woolley
Journal:  Brain Struct Funct       Date:  2011-10-11       Impact factor: 3.270

7.  Electrophysiological and morphological characteristics and synaptic connectivity of tyrosine hydroxylase-expressing neurons in adult mouse striatum.

Authors:  Osvaldo Ibáñez-Sandoval; Fatuel Tecuapetla; Bengi Unal; Fulva Shah; Tibor Koós; James M Tepper
Journal:  J Neurosci       Date:  2010-05-19       Impact factor: 6.167

8.  Dopamine synthesis by non-dopaminergic neurons in the arcuate nucleus of rat fetuses.

Authors:  V I Mel'nikova; A V Lavrent'eva; V S Kudrin; K S Raevskii; M V Ugryumov
Journal:  Neurosci Behav Physiol       Date:  2005-10

9.  Synaptic microcircuitry of tyrosine hydroxylase-containing neurons and terminals in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys.

Authors:  Maney Mazloom; Yoland Smith
Journal:  J Comp Neurol       Date:  2006-04-01       Impact factor: 3.215

10.  Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease.

Authors:  Kyota Fujita; Toshihiro Seike; Noriko Yutsudo; Mizuki Ohno; Hidetaka Yamada; Hiroo Yamaguchi; Kunihiko Sakumi; Yukiko Yamakawa; Mizuho A Kido; Atsushi Takaki; Toshihiko Katafuchi; Yoshinori Tanaka; Yusaku Nakabeppu; Mami Noda
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.